Newsroom

CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, Jan. 19, 2021 /PRNewswire/ — Celdara Medical, LLC (“Celdara”) today announced that the National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH) has awarded it a two-year Small Business Technology Transfer Research (STTR) grant to fund the development of a novel, broad-spectrum therapeutic/prophylactic […]

The problem is painful and obvious: while epic sums are being spent, every day more people are dying, and we are all living with fewer freedoms. We would not choose to begin the design of our weapons after declaring war. Why did we choose to start developing life-saving medicines against infectious diseases […]

Leading Scientists Join Together to Prepare for the Next Global Pandemic CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, Oct. 20, 2020 /PRNewswire/ — Celdara Medical announced today the launch of the Pandemic Security Initiative’s Scientific Advisory Board (SAB), a group of outstanding scientists and infectious disease experts. The SAB is an integral part of […]

CAMBRIDGE, MA. and LEBANON, NH. and NEW YORK, NY. Aug. 12, 2020 /PRNewswire/ — Celdara Medical (“Celdara”) announced that the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Small Business Innovation Research (SBIR) grant to fund the company’s development of […]

Celdara Medical today announced the launch of its Pandemic Security Initiative, harnessing the resources needed to prepare the nation for future infectious disease pandemics.